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Objectives. This study compared the long-term clinical results 
of coronary artery bypass surgery in patients with internal 
thoracic artery grafts with those in patients with vein grafts only. 
Background. Aortocoronary artery bypass surgery has been 
performed for >25 years, primarily utilizing the saphenous vein 
and internal thoracic artery as conduits. Although the internal 
thoracic artery has been shown to confer a clinical advantage, it is 
not known for how many years this benefit will continue. 
Methods. All consecutive patients undergoing initial coronary 
artery bypass urgery between 1970 and 1973 were followed for up 
to 20 years. Clinical evaluation included survival, late myocardial 
infarction, need for reoperation and recurrence of angina. Pa- 
tients were analyzed in three groups: vein grafts only (214 
patients); a single internal thoracic artery graft with or without 
associated vein grafts (490 patients); and bilateral internal tho- 
racic artery grafts (39 patients). Use of the operating microscope 
was also analyzed with regard to effect on survival. 
Results. The internal thoracic artery graft and use of the 
operating microscope were independent predictors of mortality 
and reduced the risk of dying by a factor of 0.68 and 0.76, 
respectively. An internal thoracic artery graft resulted in a mean 
survival of 4.4 years longer than that with vein grafts alone. The 
internal thoracic artery graft compared with vein grafts was 
associated with fewer reoperations (p < 0.001), fewer late myo- 
cardial infarctions, lower associated mortality rates (p < 0.04) 
and less early recurrence of angina (p = 0.03). 
Conclusions. The internal thoracic artery graft and use of the 
operating microscope confer a superior clinical advantage over 
the saphenous vein graft throughout a 20-year follow-up period. 
The advantage of an internal thoracic artery graft does not 
decrease with time, suggesting that the choice of conduit at the 
initial operation is more important clinically than progression of 
coronary artery disease. 
(J Am Coll Cardiol 1995;25:188-92) 
Aortocoronary artery bypass surgery has been performed in 
the United States for >25 years. In 1967 (1) the technique of 
saphenous vein bypass grafting was introduced and followed 
1 year later with the use of the internal thoracic artery (2). The 
internal thoracic artery bypass has been shown in many centers 
to yield superior clinical results at 7 (3), 10 (4) and 15 years (5), 
and it is now considered the conduit of choice at most centers. 
Saphenous vein grafts have been demonstrated to develop 
accelerated atherosclerosis, so that by 10 years at least 50% 
demonstrate significant disease (either total obstruction or 
severe stenosis [6,7]), whereas the internal thoracic artery graft 
remains patent and resistant to atherosclerosis. Progression of 
coronary artery disease in native coronary arteries is not 
affected by choice of conduit, so the question arises whether 
the beneficial effects of the internal thoracic artery graft will 
continue to dominate long-term survival and clinical course or 
whether progression of disease in the native vessels will be the 
determining factor. 
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St Luke's Hospital Center has had an early large surgical 
experience utilizing the internal thoracic artery bypass graft 
and has maintained clinical follow-up of its initial 743 patients. 
This experience over a 20-year period is reviewed in this 
report. 
Methods  
During the period June 1, 1970 to December 31, 1973, 743 
consecutive patients had an initial coronary artery bypass 
procedure that included both the internal thoracic artery and 
the saphenous vein. Excluded from this study were patients 
undergoing reoperation for coronary artery bypass or associ- 
ated valve or aneurysm surgery. No patient was excluded for 
any other reason, and the study group included patients with a 
recent myocardial infarction and unstable angina. Patients with 
abnormal ventricular function had an ejection fraction <50% or 
one or more segments deemed to be severely hypokinetic, 
akinetic or dyskinetic by right anterior oblique ventriculography. 
Operative techniques. Preoperative assessment and oper- 
ative techniques for this study group have been described 
elsewhere (8). Of the 743 patients, 490 (66%) had one internal 
thoracic artery graft with or without additional vein grafts, and 
39 (5%) had bilateral internal thoracic artery grafts. The vein 
grafts in the remaining 214 patients were reversed saphenous 
veins from the lower leg, except for a cephalic vein in one 
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patient. The internal thoracic artery grafts were all pedicled 
grafts with the exception of two free grafts. No sequential 
grafts were performed. Bypass was performed with the aid of 
an operating microscope in 66% of procedures and a magni- 
fying loupe in 34%. An endarterectomy was performed in only 
two patients. 
Method of follow-up. All patients were initially followed up 
by an annual outpatient evaluation i  a standardized format by 
one of three staff cardiologists. In subsequent years, follow-up 
was achieved by mail-in questionnaires, telephone interviews, 
review of records from personal physicians and from hospital 
admission records. 
Statistical methods. Data were analyzed for three groups: 
single internal thoracic artery bypass grafts (490 patients); 
bilateral internal thoracic artery bypass grafts (39 patients); 
and vein bypass grafts only (214 patients). Patients with a vein 
bypass graft who received an internal thoracic artery graft at 
reoperation remained in the vein graft group for the purpose 
of this analysis. Cumulative survival curves were determined by 
actuarial methods (9), and the results were analyzed by the 
chi-square method, with p < 0.05 considered significant. 
Comparisons of patients receiving internal thoracic artery or 
vein grafts only were performed by both univariate and multi- 
variate analyses with the Cox regression model. 
Resu l ts  
The study included 640 men (average age 50.9 years) and 
103 women (average age 53.9). Duration of follow-up was 5 to 
247 months (average of 206), and there was complete follow- 
up for 95.8% at 5 years, 90.6% at 10 years and 82% at 15 years. 
Comparison of internal thoracic artery and vein graft 
groups. As previously reported (5), patients who received an 
internal thoracic artery graft were less likely to be women 
(12% vs. 18%, p < 0.05), more often had left anterior 
descending coronary artery disease (75% vs. 25%, p < 0.001) 
and were less likely to have left main coronary artery disease 
(9% vs. 14%, p < 0.05), abnormal left ventricular function 
(47% vs. 58%, p < 0.05) or incomplete revascularization (17% 
vs. 29%, p < 0.001) than those receiving only vein grafts. 
However, the two groups did not differ with regard to age, 
presence of diabetes, hypertension, preoperative or postoper- 
ative smoking, previous myocardial infarction or number of 
vessels diseased. 
Survival rates. The presence of an internal thoracic artery 
graft and use of the operating microscope (Table 1) were both 
identified as independent predictors of mortality and reduced 
the risk of dying by factors of 0.68 and 0.76, respectively. 
Predictors of increased mortality were female gender, incom- 
plete revascularization, presence of left main coronary artery 
disease and increasing number of grafts. Impaired ventricular 
function, as well as these predictors, was identified as a 
significant predictor of mortality in multivariate analysis of the 
587 patients for whom ventriculograms were available. Al- 
though patients operated on in the first year of this study 
(1970) had a poorer prognosis (p = 0.04) than the other years 
Table 1. Independent Predictors of Mortality in 743 Patients 
Factor p Value Relative Risk 
Female gender 0.001 1.67 
Incomplete r vascularization < 0.001 1.66 
LMCA 0.03 1.43 
No. of grafts < 0.001 1.40 
Microscope 0.03 0.76 
ITA graft 0.003 0.68 
ITA - internal thoracic artery; LMCA = left main coronary artery. 
(1971 to 1973), the addition of the year of operation to the 
multivariate analysis did not change the results. The use of 
internal thoracic artery grafts and the operating microscope 
remained independent predictors of survival (p = 0.03 and p = 
0.007, respectively). Cumulative survival rates (Fig. 1), which 
included operative deaths, were 38% for vein grafts and 50% 
for a single intemal thoracic artery graft (both at 20 years) and 
63.5% for bilateral internal thoracic artery grafts (at 19 years, 
p = 0.004). The internal thoracic artery graft groups had better 
operative as well as long-term survival rates than the vein graft 
group. No patient with bilateral internal thoracic artery grafts 
died before the fifth year. The mean survival with a single ITA 
graft was 4.4 years longer than that with vein grafts alone. The 
cumulative survival rates (Table 2) were significantly improved 
by an internal thoracic artery graft in those patients receiving 
single or double bypass grafts. In the single-bypass group, the 
left anterior descending coronary artery was bypassed 99% of 
the time in the internal thoracic artery graft group but only 
60% of the time in the vein graft group. In those patients 
receiving three or more grafts, the 20-year survival rates of 
40% versus 26.6% were not significantly different, most likely 
because of the small number of patients receiving three or 
more grafts in the vein graft-only group. 
Angina pectoris. Angina, including all exertional chest 
pains, occurred in the first year in 18% of those receiving an 
Figure 1. Cumulative survival rates for 490 patients with a single 
internal thoracic artery (ITA) graft, 39 patients with bilateral internal 
thoracic artery grafts and 214 patients with vein grafts only. 
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Table 2. Number of Grafts and 20-Year Cumulative Survival Rates 
ITA Veins 
No. of No. of CSR No. of CSR p 
Grafts Pts (% + SE) Pts (% + SE) Value 
1 82 78.4 ± 6.3 50 59.1 _+ 10.0 0.04 
2 172 52.9 _+ 6.6 76 31.5 ± 9.4 < 0.00l 
3 236 40.0 _+ 10.4 88 26.6 + 12.5 NS 
CSR = cumulative survival rate; ITA - internal thoracic artery; Pts = 
patients. 
internal thoracic artery graft and in 26% of those receiving vein 
grafts only (Fig. 2). This difference, significant at the p = 0.03 
level, was not sustained. By the seventh year, the curves were 
similar, with 50% of patients experiencing angina ->11 years 
postoperatively in both groups. 
Myocardial infarction. Late myocardial infarction in- 
cluded all heart attacks reported by the patients as well as any 
documented by review of medical records. There were 216 
infarctions, with 67 in the vein graft and 136 in the single 
internal thoracic artery graft and 13 in the bilateral internal 
thoracic artery graft groups. The rates are significantly differ- 
ent after the 10th year and are no longer significant after the 
19th year (Fig. 3), perhaps because of the small number of 
patients followed up. Mortality rates associated with late 
myocardial infarction were 32.8% (22 of 67) for those with vein 
grafts only, 19.1% (26 of 136) for those with a single internal 
thoracic artery graft and 7.7% (1 of 13) for those with a double 
internal thoracic artery graft and were significantly different at 
the p < 0.04 level. From the available records, it was not 
possible to determine from the location of these infarctions 
whether a failed vein or internal thoracic artery graft was 
responsible for the infarction. 
Reoperation. Reoperation for recurrence of symptoms of 
coronary artery disease (Fig. 4) was performed in 94 patients, 
and 3 had a second reoperation. The average annual rate for 
the first reoperation over a 20-year period was 2.5% for the 
vein graft group and was significantly different from that of 
0.9% for the single internal thoracic artery graft group (p < 
Figure 2. Annual recurrence of angina pectoris n 477 patients with a 
single internal thoracic artery (ITA) graft and 205 patients with vein 
grafts only. 
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Figure 3. Cumulative rate of late myocardial nfarctions over a 20-year 
period in 477 patients with a single internal thoracic artery (ITA) graft 
and 205 patients with vein grafts only. 
0.001). In the bilateral internal thoracic artery graft group only 
two patients had a reoperation. Although mortality rates 
associated with reoperation were lower for the internal tho- 
racic artery graft group, they were not significantly different. 
The operative mortality rate for a previous internal thoracic 
artery graft was 6.4% (3 of 47), and that for vein grafts only was 
11.1% (5 of 45). Unlike reoperation, there was no difference in 
the cumulative rates of angioplasty in these patients, with 
-12% of both groups of patients, with or without an internal 
thoracic artery graft, having angioplasty by the 20th year. 
Discuss ion 
Survival. The beneficial influence of a single internal tho- 
racic artery graft on survival has been well documented in
many studies (3-5), all showing improved survival rates with an 
internal thoracic artery graft. Other observational studies 
comparing single and double internal thoracic artery grafts 
(10,ll) have demonstrated a benefit in terms of both survival 
and freedom from cardiac events. The additional benefit from 
a second internal thoracic artery graft is not expected to be as 
powerful because the first will have most likely been placed at 
the left anterior descending coronary artery, the coronary 
artery with the most clinical significance (12,13). The clinical 
advantage ofa second internal thoracic artery graft o the right 
or circumflex coronary artery would not be expected to be as 
great. The improved survival with an internal thoracic artery 
graft is undoubtedly due to the superior patency rates of the 
internal thoracic artery, which, if patent immediately postop- 
eratively, remains o, whereas vein grafts are subject o pro- 
gressive accelerated atherosclerosis (6). Distal coronary artery 
disease does not appear to be a major determinant of survival 
rate because, presumably, the rate of development of coronary 
obstructive disease distal to the graft anastomosis would be 
similar whether the source of the graft was an internal thoracic 
artery or a vein, and the present follow-up study shows 
superior esults in patients with an internal thoracic artery 
graft. Thus, the patency of the bypass graft itself must be 
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Figure 4. Cumulative rate of first reoperation for coronary artery 
disease over a 20-year period in 477 patients with a single internal 
thoracic artery (ITA) graft and 205 patients with vein grafts only. 
responsible for the significantly improved survival rates with, as 
noted in this report, an additional mean survival of 4.5 years 
attributable to an internal thoracic artery graft. 
Operating microscope. The present study is unique be- 
cause of the frequent use of the operating microscope, which 
was used in 66% of the bypass operations performed. This 
technique was used for both arterial and venous grafts. Other 
features of surgical technique, namely myocardial preserva- 
tion, anesthesia nd general perioperative management, were 
the same for all surgeons in this study. It is not possible to 
separate the influence of the use of the operating microscope 
from other aspects of an individual surgeon's kill in perform- 
ing coronary anastomoses. These aspects include the number 
of sutures, proximity of the sutures to the margins of the 
anastomoses, angle of the anastomoses and the prevention of 
disruption of the layers of the vessel wall. However, surgeons 
who use the operating microscope believe that all of these 
aspects are favorably influenced by the use of the microscope. 
The beneficial influence on survival with an operating micro- 
scope presumably is attributable to superior patency rates of 
the arterial and venous grafts. 
The slopes of the curves both for cumulative survival rates 
(Fig. 1) and reoperation rates (Fig. 4) appear to become 
steeper at 10 years in the single internal thoracic artery graft 
group and even more markedly in the vein graft group. This 
change in slope accounts for a further separation of the two 
curves toward the end of the study period. This break in the 
curves at 10 years occurs at the time when most studies (6,7) 
document he greatest attrition in vein grafts. Lawrie et al. 
(14), in a large group of patients with vein grafts only, also 
found a change in the reoperation rate at 9 years, with an 
increase in the annual rate of 1% to 2.5%. Thus, the higher 
reoperation rates and lower cumulative survival rates for the 
vein graft only group are most likely due to vein graft failure. 
Angina. The beneficial influence of an internal thoracic 
artery graft on early recurrence of angina is not sustained. 
Angina occurring late after bypass urgery is likely due to vein 
graft failure or progression of disease. In this study, 83% of 
patients in the single internal thoracic artery graft group had 
associated vein grafts. The incidence of myocardial infarctions 
and most importantly the associated mortality rates were lower 
in patients with an internal thoracic artery graft, most likely 
due to the protective influence of a patent internal thoracic 
artery graft to the left anterior descending coronary artery. 
Autopsy studies (10) of patients with fatal acute myocardial 
infarction have shown that lesions occur most frequently in the 
left anterior descending coronary artery. 
Reoperation. In patients with vein grafts only, reoperation 
was not only required more often, but was associated with 
higher operative mortality rates. Although some (15) have 
cautioned against use of an internal thoracic artery graft at the 
first operation so as to decrease the risk of a second operation, 
other studies (16) have agreed with the present study that the 
presence of a patent internal thoracic artery graft at reopera- 
tion does not increase the hazard of the reoperation. Undoubt- 
edly, newer myocardial protection techniques have reduced 
mortality and morbidity of reoperations in the presence of 
patent internal thoracic artery grafts. 
Study limitations. This study is an observational study with 
the usual criticism of bias in selection. The patients elected for 
surgery in the years 1970 to 1973 were not as sick as those 
currently referred for surgery and undoubtedly included pa- 
tients currently considered to be candidates for balloon angio- 
plasty or other interventional techniques. Despite these draw- 
backs, the study shows the continued beneficial influence of an 
internal thoracic artery graft on survival and clinical events 
over 20 years. The evidence that the beneficial influence of the 
internal thoracic artery graft is still apparent at 20 years implies 
that the choice of conduit at the initial operation is a more 
important influence on survival than progression of disease in 
unbypassed vessels or in bypassed vessels distal to the graft 
anastomotic site. 
Conclusions. We believe that this study is the first to 
suggest hat the use of the operating microscope yields supe- 
rior clinical results. This finding is not surprising considering 
that the coronary vessels are usually 1.5 to 2 mm in diameter. 
What is surprising is that more cardiovascular surgeons do not 
avail themselves and their patients of the benefit of magnification 
of 8 to 12x magnitude, as was done in this study. It is common- 
place for surgeons performing neurologic, ophthalmic, gyneco- 
logic, urologic and middle ear procedures all to use the operating 
microscope. The results of this report should encourage cardio- 
vascular surgeons to use this technique as well. 
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